Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with immunodepression in France in 2020 (multivariab... by Benjamin Wyplosz (22032756)

Subjects:

Pneumococcal (black bars) and influenza (white bars) vaccine coverage in patients living with comorbidities (A), and immunosuppressive conditions (B), who are at risk of pneumococc... by Benjamin Wyplosz (22032756)

Subjects:

The sentiment score and number of tweets per month from 09/01/2018 to 01/31/2020. by Yuqi Zhang (286958)

Subjects:

Study population: patients living with comorbidities (on the left) and immunosuppressive conditions (on the right) who are at risk of pneumococcal disease in France in the year 202... by Benjamin Wyplosz (22032756)

Subjects:

Characteristics associated with pneumococcal primary vaccination (A) and 2020−21 seasonal influenza vaccination (B) in patients with comorbidities in France in 2020 (multivariable... by Benjamin Wyplosz (22032756)

Subjects:

The theme, top terms, and description of five topic groups. by Yuqi Zhang (286958)

Subjects:

Characteristics of patients at risk of pneumococcal disease in France in 2020 and vaccination rates. by Benjamin Wyplosz (22032756)

Subjects:

Volume distribution and sentiment of positive, negative, and neutral tweets. by Yuqi Zhang (286958)

Subjects:

Concurrent mixed methods design diagram. by Esario IV Daguman (21474116)

Subjects:

Outcomes and data gathering timeline. by Esario IV Daguman (21474116)

Subjects:

The guiding map. by Esario IV Daguman (21474116)

Subjects:

Technical properties of tested UASs. by Marc Roswag (20598443)

“…Our results support this hypothesis, because multicopter flights have a highly significant negative impact on bat activity levels with a medium effect size, particularly for the Myotini (<i>P</i> < 0.001, <i>d</i>_<i>m</i> = 0.54) and Nyctaloid group (<i>P</i> < 0.001, <i>d</i>_<i>n</i> = 0.55) and a small effect size for the Pipistrelloid group (<i>P</i> < 0.001, <i>d</i>_<i>p</i> = 0.36). …”

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) STZ mice show changes in glomerular morphology. by Andrey V. Cybulsky (4007012)

Subjects:

Control (Ctrl) GECs are more susceptible to injury compared to iPLA₂γ KO GECs. by Andrey V. Cybulsky (4007012)

Subjects:

Podocyte numbers in control and iPLA₂γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

Subjects:

Primary data. by Andrey V. Cybulsky (4007012)

Subjects:

Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality. by Jennifer M. Kwan (3350321)

Subjects:

Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

Subjects:

Adverse cardiovascular events by immune checkpoint inhibitor. by Jennifer M. Kwan (3350321)

Subjects: